Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion type Assertion NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_head.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion description "[The CYP1B1 V432L homozygous variant was associated with decreased risk of meningioma (odds ratio [OR] = 0.6; 95% CI, 0.3-1.0) but not the other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_provenance.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion evidence source_evidence_literature NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_provenance.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion SIO_000772 16598069 NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_provenance.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion wasDerivedFrom befree-20140225 NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_provenance.
- NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_assertion wasGeneratedBy ECO_0000203 NP503317.RAadQg2t2VMtZdLz06FmTmIHpbwQc5mMH7H_uybSHJ460130_provenance.